INDmoney
Pacira Pharmaceuticals, Inc. Stock Performance
as on March 3, 2026 at 7:59 am IST
Day's Low
Day's High
$21.28$22.30
0.09%
Downside
4.69%
Upside
52 Week's Low
52 Week's High
$18.80$27.6411.74%
Downside
29.77%
Upside
Pacira Pharmaceuticals, Inc. share price movements today
- Previous Close
- $21.91
- Open
- $21.57
- Volume
- 1.1M
- Day's Low - High
- $21.28 - $22.30
- 52 Week Low - High
- $18.80 - $27.64
Pacira Pharmaceuticals, Inc. Historical Returns
- 1 Month Return
- + 1.24 %
- 3 Month Return
- -12.03 %
- 1 Year Return
- -7.32 %
- 3 Year Return
- -49.39 %
- 5 Year Return
- -69.32 %
Pacira Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators
Check Pacira Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$942.6M
EPS (TTM)
2.612
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.88%
PE Ratio (TTM)
46.62
Industry PE ratio
-3.105112781954887
PEG Ratio
-3.83
EBITDA
110.2M
Revenue (TTM)
726.4M
Profit Margin
0.97%
Return On Equity TTM
0.96%
Pacira Pharmaceuticals, Inc. Stock Valuation
Track how Pacira Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.
Pacira Pharmaceuticals, Inc. in the last 5 years
Lowest (5.36x)
September 30, 2024
Industry (-3.11x)
March 3, 2026
Today (46.62x)
March 3, 2026
Highest (32.47x)
March 31, 2021
Today’s Price to Earnings Ratio: 46.62x
Pacira Pharmaceuticals, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Pacira Pharmaceuticals, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $942.6M | -69.32% | 46.62 | 0.97% | |
| BUY | $23.2B | NA | 19.09 | 41.94% | |
| BUY | $49.3B | NA | 22.14 | 15.11% | |
| HOLD | $17.2B | 13.11% | -21.95 | -24.58% | |
| BUY | $57.8B | -13.64% | 21.78 | 28.24% |
Stock Returns calculator for Pacira Pharmaceuticals, Inc. Stock including INR - Dollar returns
The Pacira Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Pacira Pharmaceuticals, Inc. investment value today
Current value as on today
₹97,587
Returns
Returns from Pacira Pharmaceuticals, Inc. Stock
Dollar Returns*
₹4,817 (+4.82%)
Analyst Recommendation on Pacira Pharmaceuticals, Inc. Stock
Based on 16 analysts
93.75%
Buy
6.25%
Hold
0.00%
Sell
Based on 16 analysts, 93.75% of analysts recommend a 'BUY' rating for Pacira Pharmaceuticals, Inc.. Average target price of $29
Pacira Pharmaceuticals, Inc. Share Price Target
Get share price movements and forecasts by analysts on Pacira Pharmaceuticals, Inc..
What analysts predicted
26.55%UPSIDE
Target Price
$29
Current Price
$21.3
Analyzed by
16 Analysts
Target
$29.00
Pacira Pharmaceuticals, Inc. target price $29, a slight upside of 26.55% compared to current price of $21.3. According to 16 analysts rating.
Pacira Pharmaceuticals, Inc. Stock’s Investor Sentiment and Interest
Search interest for Pacira Pharmaceuticals, Inc. Stock has decreased by -81% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Pacira Pharmaceuticals, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Pacira Pharmaceuticals, Inc. Annual Profit & Loss
All numbers in Millions USD
Pacira Pharmaceuticals, Inc. Quarterly Cash Flow
All numbers in Millions USD
Pacira Pharmaceuticals, Inc. Annual Cash Flow
All numbers in Millions USD
Pacira Pharmaceuticals, Inc. News & Key Events
Today's Timeline - 21 October
Tue, 06:05 PM
-Pacira Biosciences received a PIV Notice from WhiteOak regarding a generic version of EXPAREL, asserting patent invalidity.
Insights on Pacira Pharmaceuticals, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 179.51M → 196.87M (in $), with an average increase of 8.8% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -4.84M → 21.31M (in $), with an average increase of 131.9% per quarter
NO EFFECTAgainst Peers
In the last 3 years, United Therapeutics Corporation has given 102.6% return, outperforming this stock by 150.5%
- NO EFFECT
Against Peers
In the last 1 year, United Therapeutics Corporation has given 62.5% return, outperforming this stock by 67.1%
NEGATIVE IMPACTPrice Dip
In the last 7 days, PCRX stock has moved down by -6.4%
About Pacira Pharmaceuticals, Inc.
| Organisation | Pacira Pharmaceuticals, Inc. |
| Headquarters | 2000 Sierra Point Parkway, Brisbane, CA, United States, 94005 |
| Industry | Health Technology |
| CEO | Mr. Frank D. Lee |
| E-voting on shares | Click here to vote |
Key Management of Pacira Pharmaceuticals, Inc.
Name | Title |
|---|---|
Ms. Lauren Bullaro Riker | Principal Accounting Officer & Senior VP of Finance |
Ms. Susan Mesco | Head of Investor Relations |
Mr. Anthony Molloy III, Esq. | Chief Legal & Compliance Officer |
Mr. Christopher C. Young | Chief Manufacturing Officer |
Mr. Shawn M. Cross | Chief Financial Officer |
Ms. Kristen Williams Esq., J.D. | Chief Administrative Officer & Secretary |
Dr. Jonathan Slonin M.D. | Chief Medical Officer |
Ms. Krys Corbett Esq. | Chief Business Officer |
Mr. Brendan P. Teehan | Chief Commercial Officer |
Mr. Frank D. Lee | CEO & Director |
FAQs
What is Pacira Pharmaceuticals, Inc. share price today?
Pacira Pharmaceuticals, Inc. share price today is $21.3 as on at the close of the market. Pacira Pharmaceuticals, Inc. share today touched a day high of $22.3 and a low of $21.28.
What is the 52 week high and 52 week low for Pacira Pharmaceuticals, Inc. share?
Pacira Pharmaceuticals, Inc. share touched a 52 week high of $27.64 on and a 52 week low of $18.8 on . Pacira Pharmaceuticals, Inc. stock price today i.e. is closed at $21.3,which is 22.94% down from its 52 week high and 13.30% up from its 52 week low.
What is Pacira Pharmaceuticals, Inc.'s market capitalisation today?
Pacira Pharmaceuticals, Inc. market capitalisation is $0.00T as on .
How to invest in Pacira Pharmaceuticals, Inc. Stock (PCRX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Pacira Pharmaceuticals, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pacira Pharmaceuticals, Inc. Shares that will get you 0.0704 shares as per Pacira Pharmaceuticals, Inc. share price of $21.3 per share as on March 3, 2026 at 2:29 am IST.
What is the minimum amount required to buy Pacira Pharmaceuticals, Inc. Stock (PCRX) from India?
Indian investors can start investing in Pacira Pharmaceuticals, Inc. (PCRX) shares with as little as ₹91.474 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹914.74 in Pacira Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Pacira Pharmaceuticals, Inc. share’s latest price of $21.3 as on March 3, 2026 at 2:29 am IST, you will get 0.4695 shares of Pacira Pharmaceuticals, Inc.. Learn more about
fractional shares .
What are the returns that Pacira Pharmaceuticals, Inc. has given to Indian investors in the last 5 years?
Pacira Pharmaceuticals, Inc. stock has given -69.32% share price returns and 24.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?